Rapid Screening of Novel Agents for Combination Therapy in Sarcomas
Figure 3
MRI imaging response to combination therapy in Ewing sarcoma. T2-weighted fast spin-echo images (TE/TR = 72/2400 ms) with a resolution of 312 mm demonstrating the tumor sizes in dasatinib (a), combination (b), triciribine (c), and untreated (d) at day 6. Representative datasets were chosen to reflect the overall trend of tumor size and growth. Lesions are indicated by arrows.
